Kringle Pharma
4884.TPharmaceutical
Filed as Kringle Pharma, Inc. (2022-08–2026-05), Kringle Pharma, Inc (2023-05–2023-05)
Major holders (5%+) · 0
| Holder | Stake |
|---|
No holder currently reports 5% or more.
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 6
| Evo Fund | 4.79% |
| Barclays Bank PLC | 4.39% |
| TOHOKU University Venture Partners | 3.07% |
| Barclays Capital Securities Ltd. | 0.21% |
| Barclays Securities Japan Limited | 0.06% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 33
| Holder | Ratio | Change |
|---|---|---|
| Evolution Capital Management LLC2026-05-20 · amended | 0.00% | no change |
| Evo Fund2026-05-20 · amended | 8.45% | +3.66pp |
| Evolution Capital Management LLC2025-08-08 · amended | 0.00% | no change |
| Evo Fund2025-08-08 · amended | 4.79% | -1.22pp |
| Evolution Capital Management LLC2025-08-08 · amended | 0.00% | no change |
| Evo Fund2025-08-08 · amended | 6.01% | -0.16pp |
| Evolution Capital Management LLC2025-08-08 · amended | 0.00% | no change |
| Evo Fund2025-08-08 · amended | 6.17% | -1.22pp |
| Evolution Capital Management LLC2025-08-08 · amended | 0.00% | no change |
| Evo Fund2025-08-08 · amended | 7.39% | -2.17pp |
| Evolution Capital Management LLC2025-08-08 · amended | 0.00% | no change |
| Evo Fund2025-08-08 · amended | 9.56% | -3.64pp |
| Evolution Capital Management LLC2025-08-08 · amended | 0.00% | no change |
| Evo Fund2025-08-08 · amended | 13.20% | -4.35pp |
| Evolution Capital Management LLC2025-08-08 · amended | 0.00% | no change |
| Evo Fund2025-08-08 · amended | 17.55% | -1.10pp |
| Evolution Capital Management LLC2025-08-08 · amended | 0.00% | no change |
| Evo Fund2025-08-08 · amended | 18.65% | -1.42pp |
| Evolution Capital Management LLC2025-08-08 · amended | 0.00% | no change |
| Evo Fund2025-08-08 · amended | 20.07% | -0.25pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.